Larson Financial Group’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$89.2K Buy
7,246
+236
+3% +$2.96K ﹤0.01% 1293
2026
Q2
$103K Sell
7,010
-3
-0% -$21 ﹤0.01% 1166
2026
Q1
$29.7K Buy
7,013
+20
+0.3% +$89 ﹤0.01% 1632
2025
Q4
$26.4K Buy
+6,993
New +$13.6K ﹤0.01% 1560

Other funds holding SLS

Larson Financial Group's SLS Position: Q3 2026 in Review

Larson Financial Group increased its SELLAS Life Sciences (SLS) stake by 3.4% in Q3 2026, buying an estimated $2.96K and bringing the position to 7,246 shares worth $89.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

Larson Financial Group first reported a position in SLS in Q4 2025 and has held it in 4 quarters since. The position peaked at $103K in Q2 2026. 218 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Larson Financial Group held 7,246 shares of SELLAS Life Sciences worth $89.2K as of Q3 2026.
  • Larson Financial Group bought 236 SELLAS Life Sciences shares in Q3 2026, an estimated $2.96K.
  • SELLAS Life Sciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1293 holding.
  • Larson Financial Group first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 4 quarters since.
  • Larson Financial Group's SELLAS Life Sciences position peaked at $103K in Q2 2026.
  • 218 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.